
A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study
Keywords: پیلونفریت; Pyelonephritis; Ertapenem; Extended-spectrum beta lactamase (ESBL); Escherichia coli; Sitafloxacin;